您的位置: 首页 > 农业专利 > 详情页

Modulating regulatory T cell activity via Interleukin 35
专利权人:
St. Jude Children's Research Hospital;St. Jude Childrens Research Hospital
发明人:
Workman, Creg,Vignali, Dario,Collison, Lauren,Vignali, Kate
申请号:
AU2007298571
公开号:
AU2007298571B2
申请日:
2007.09.24
申请国别(地区):
AU
年份:
2012
代理人:
摘要:
Methods for regulating T cell function in a subject, particularly regulatory T cell activity are provided. Methods of the invention include administering to a subject a therapeutically effective amount of an Interleukin 35 -specific binding agent, such as an antibody or small molecule inhibitor. The invention further provides methods for enhancing the immunogenicity of a vaccine or overcoming a suppressed immune response to a vaccine in a subject, including administering to the subject a therapeutically effective amount of an IL35-specific binding agent and administering to the subject a vaccine. In one embodiment the vaccine is a cancer vaccine.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充